financetom
Business
financetom
/
Business
/
BRIEF-German Cartel Office: Authorised KKR's Acquisition Of Majority Of Shares In FGS Global
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-German Cartel Office: Authorised KKR's Acquisition Of Majority Of Shares In FGS Global
Sep 3, 2024 8:13 AM

Sept 3 (Reuters) - GERMAN CARTEL OFFICE:

* HAVE AUTHORISED ACQUISITION OF MAJORITY OF SHARES AND SOLE

CONTROL OF CONSULTING FIRM FGS GLOBAL BY INVESTMENT COMPANY KKR

Source text: [https://bit.ly/3ARXyqE]

(Reporting by Berlin Newsroom)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Currencies consolidate as dollar steadies, euro hangs near one-month low
Currencies consolidate as dollar steadies, euro hangs near one-month low
Jun 16, 2024
TOKYO (Reuters) -The dollar was firm on Monday as the euro hovered near a more than one-month low amid political turmoil in Europe, while investors awaited fresh clues on the strength of the U.S. economy. Investors have been contemplating the risk of a budget crisis at the heart of the euro area, as far right and leftist parties gain momentum...
Australia's Tabcorp appoints former AFL boss Gillon McLachlan as CEO
Australia's Tabcorp appoints former AFL boss Gillon McLachlan as CEO
Jun 16, 2024
(Reuters) - Australian gambling services firm Tabcorp Holdings ( TABCF ) on Monday appointed former Australian Football League (AFL) boss Gillon McLachlan as its chief executive and managing director. The appointment comes months after former chief Adam Rytenskild resigned over allegedly using offensive and inappropriate language at the workplace and as the firm navigates a strategic transformation amid heightened competition...
AstraZeneca's Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer
AstraZeneca's Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer
Jun 16, 2024
June 17 (Reuters) - AstraZeneca's ( AZN ) blockbuster cancer drug Imfinzi combined with chemotherapy has been approved in the U.S. as treatment for adult patients with primary, advanced or recurrent endometrial cancer that is mismatch repair deficient, the drugmaker said. ...
UBS to book $0.9 billion provision linked to inherited Greensill funds
UBS to book $0.9 billion provision linked to inherited Greensill funds
Jun 16, 2024
ZURICH (Reuters) - UBS expects to record a provision of around $0.9 billion, the Swiss bank said on Monday, in connection to Credit Suisse's funds linked to collapsed supply chain financing firm Greensill Capital. The Credit Suisse Supply Chain Finance Funds have made an offer to redeem fund units, UBS said. Fund investors who choose to accept the offer will...
Copyright 2023-2025 - www.financetom.com All Rights Reserved